Year |
Citation |
Score |
2020 |
Hungria V, Martínez-Baños DM, Mateos MV, Dimopoulos MA, Cavo M, Heeg B, Garcia A, Lam A, Machnicki G, He J, Fernandez M. Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis. Advances in Therapy. PMID 33067698 DOI: 10.1007/s12325-020-01521-9 |
0.351 |
|
2019 |
Hungria VT, Martinez-Banos DM, Mateos M, Dimopoulos MA, Cavo M, Heeg B, Lam A, Machnicki G, He J, Fernandez M. Comparison of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) with Standard of Care for Patients from Latin America with Newly Diagnosed Multiple Myeloma (NDMM) Who Were Transplant Ineligible: A Propensity Score Matching Analysis Blood. 134: 2143-2143. DOI: 10.1182/blood-2019-123557 |
0.313 |
|
2011 |
Machnicki G, Lentine KL, Salvalaggio PR, Burroughs TE, Brennan DC, Schnitzler MA. Kidney transplant Medicare payments and length of stay: associations with comorbidities and organ quality. Archives of Medical Science : Ams. 7: 278-86. PMID 22291768 DOI: 10.5114/Aoms.2011.22079 |
0.753 |
|
2011 |
Woodward RS, Flore MC, Machnicki G, Brennan DC. The long-term outcomes and costs of diabetes mellitus among renal transplant recipients: tacrolimus versus cyclosporine. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 14: 443-9. PMID 21315636 DOI: 10.1016/j.jval.2010.10.030 |
0.597 |
|
2011 |
Machnicki G, Lentine KL, Salvalaggio PR, Burroughs TE, Brennan DC, Schniztler MA. Three-year post-transplant Medicare payments in kidney transplant recipients: associations with pre-transplant comorbidities. Saudi Journal of Kidney Diseases and Transplantation : An Official Publication of the Saudi Center For Organ Transplantation, Saudi Arabia. 22: 24-39. PMID 21196610 |
0.726 |
|
2010 |
Lentine KL, Xiao H, Machnicki G, Gheorghian A, Schnitzler MA. Renal function and healthcare costs in patients with polycystic kidney disease. Clinical Journal of the American Society of Nephrology : Cjasn. 5: 1471-9. PMID 20538839 DOI: 10.2215/Cjn.00780110 |
0.618 |
|
2009 |
Dmitrienko S, Balshaw R, Machnicki G, Shapiro RJ, Keown PA. Probabilistic modeling of cytomegalovirus infection under consensus clinical management guidelines. Transplantation. 87: 570-7. PMID 19307796 DOI: 10.1097/Tp.0B013E3181949E09 |
0.446 |
|
2009 |
Machnicki G, Pinsky B, Takemoto S, Balshaw R, Salvalaggio PR, Buchanan PM, Irish W, Bunnapradist S, Lentine KL, Burroughs TE, Brennan DC, Schnitzler MA. Predictive ability of pretransplant comorbidities to predict long-term graft loss and death. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 9: 494-505. PMID 19120083 DOI: 10.1111/J.1600-6143.2008.02486.X |
0.701 |
|
2008 |
Machnicki G, Ricci JF, Brennan DC, Schnitzler MA. Economic impact and long-term graft outcomes of mycophenolate mofetil dosage modifications following gastrointestinal complications in renal transplant recipients. Pharmacoeconomics. 26: 951-67. PMID 18850764 DOI: 10.2165/00019053-200826110-00007 |
0.686 |
|
2008 |
Machnicki G, Pefaur J, Gaite L, Linchenco AM, Raimondi C, Schiavelli R, Otero A, Margolis MK. Gastrointestinal (GI)-Specific patient reported outcomes instruments differentiate between renal transplant patients with or without GI symptoms: results from a South American cohort. Health and Quality of Life Outcomes. 6: 53. PMID 18644133 DOI: 10.1186/1477-7525-6-53 |
0.428 |
|
2008 |
Neri L, Rocca Rey LA, Pinsky BW, Lentine KL, Salvalaggio PR, Machnicki G, Willoughby L, Burroughs TE, Takemoto SK, Schnitzler MA. Increased risk of graft failure in kidney transplant recipients after a diagnosis of dyspepsia or gastroesophageal reflux disease. Transplantation. 85: 344-52. PMID 18301330 DOI: 10.1097/Tp.0B013E318160D4C4 |
0.756 |
|
2008 |
Lehmkuhl H, Arizon J, Almenar L, Magelli C, Gerosa G, Varnous S, Musumeci F, Mattei M-, Vanhaecke J, Mange K, Machnicki G, Livi U. DECREASE OF MAJOR CARDIAC EVENTS AND HOSPITALIZATIONS IN DE NOVO HEART TRANSPLANT RECIPIENTS RECEIVING EVEROLIMUS: RESULTS FROM A 12-MONTH, MULTICENTER, RANDOMIZED TRIAL COMPARING EVEROLIMUS WITH MMF Transplantation. 86: 240. DOI: 10.1097/01.tp.0000332064.44238.d2 |
0.38 |
|
2008 |
Lehmkuhl H, Arizon J, Almenar L, Magelli C, Gerosa G, Varnous S, Musumeci F, Mattei M, Vanhaecke J, Mange K, Machnicki G. 466: Hospitalization Days Due to Major Cardiac Events (MACE) in De Novo Heart Transplant Recipients: Data from a 12-Month, Multicenter, Randomized Trial of Everolimus Versus MMF The Journal of Heart and Lung Transplantation. 27: S228. DOI: 10.1016/j.healun.2007.11.479 |
0.37 |
|
2007 |
Burroughs TE, Lentine KL, Takemoto SK, Swindle J, Machnicki G, Hardinger K, Brennan DC, Irish WD, Schnitzler MA. Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes. Clinical Journal of the American Society of Nephrology : Cjasn. 2: 517-23. PMID 17699459 DOI: 10.2215/Cjn.00620206 |
0.718 |
|
2007 |
Burroughs TE, Swindle J, Takemoto S, Lentine KL, Machnicki G, Irish WD, Brennan DC, Schnitzler MA. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation. 83: 1027-34. PMID 17452891 DOI: 10.1097/01.Tp.0000259617.21741.95 |
0.704 |
|
2006 |
Kleinman L, Kilburg A, Machnicki G, Faull R, Walker R, Prasad R, Ambuehl P, Bahner U, Margolis MK. Using GI-specific patient outcome measures in renal transplant patients: validation of the GSRS and GIQLI. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 15: 1223-32. PMID 16972162 DOI: 10.1007/s11136-006-0053-5 |
0.477 |
|
2006 |
Schnitzler M, Machnicki G. ABO-incompatible living donor transplantation: is it economically "compatible"? Transplantation. 82: 168-9. PMID 16858277 DOI: 10.1097/01.Tp.0000226242.10027.E7 |
0.707 |
|
2006 |
Helderman J, Gilmore A, Ryskina K, Legorreta A, Naujoks C, Machnicki G. PUK4 AN ECONOMIC EVALUATION OF DE NOVO RENAL TRANSPLANT RECIPIENTS USING BRANDED (B-CSA) VS. NON-BRANDED CYCLOSPORINE MODIFIED (NB-CSA) Value in Health. 9: A385. DOI: 10.1016/S1098-3015(10)63771-0 |
0.545 |
|
2006 |
Legorreta A, Kang N, Gilmore A, Marehbian J, Naujoks C, Machnicki G. PCV19 DISCONTINUED USE OF MYCOPHENOLATE MOFETIL AND GRAFT LOSS IN HEART TRANSPLANT RECIPIENTS Value in Health. 9: A342. DOI: 10.1016/S1098-3015(10)63635-2 |
0.517 |
|
2006 |
Machnicki G, Seriai L, Schnitzler MA. Economics of transplantation: a review of the literature Transplantation Reviews. 20: 61-75. DOI: 10.1016/J.Trre.2006.05.001 |
0.67 |
|
2005 |
Machnicki G, Pinsky B, Takemoto S, Lentine K, Willoughby L, Bunnapradist S, Burroughs T, Schnitzler MA. Application of diagnostic classification algorithms to identify the most common causes of post-transplant complications. Clinical Transplants. 57-67. PMID 17424725 |
0.69 |
|
2005 |
Balshaw R, Machnicki G, Carreño CA, Toselli L, Otero A, Keown PA. Two-hour post-dose cyclosporine levels in renal transplantation in Argentina: a cost-effective strategy for reducing acute rejection. Transplantation Proceedings. 37: 871-4. PMID 15848560 DOI: 10.1097/00007890-200407271-01377 |
0.457 |
|
2004 |
Balshaw R, Keown P, Budde K, Machnicki G, Kalo Z. FTY720 VS. MYCOPHENOLATE MOFETIL, ECONOMIC IMPACT IN CYCLOSPORINE BASED IMMUNOSUPRESSION FOR DE NOVO RENAL TRANSPLANTATION Transplantation. 78: 511. DOI: 10.1097/00007890-200407271-01378 |
0.612 |
|
2004 |
Brennan DC, Kutinova A, Machnicki G, Woodward RS. THE INCIDENCE AND COSTS OF HEPATITIS BEFORE AND AFTER RENAL TRANSPLANTATION Transplantation. 78: 481. DOI: 10.1097/00007890-200407271-01294 |
0.511 |
|
2004 |
Kleinman L, Bahner U, Faull R, Walker R, Prasad R, Ambuehl P, Machnicki G, Margolis M. PGI11 PSYCHOMETRIC VALIDATION OF TWO GASTROINTESTINAL (GI)-SPECIFIC PATIENT-REPORTED OUTCOME (PRO) INSTRUMENTS IN RENAL TRANSPLANT PATIENTS WITH AND WITHOUT GI COMPLICATIONS Value in Health. 7: 756-757. DOI: 10.1016/S1098-3015(10)66014-7 |
0.478 |
|
Show low-probability matches. |